The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies
Abstract
Background: Liver biopsy is an important tool in the management of patients with liver disease. Because biopsy practices may be changing, we studied patterns of use in a large Canadian Health Region. We aimed to describe trends in biopsy utilization and the incidence and costs of complications from a population‐based perspective. Methods: Administrative databases were used to identify percutaneous liver biopsies performed between 1994 and 2002. Significant complications were identified by reviewing medical records of patients hospitalized within 7 days of a biopsy and those with a diagnostic code indicative of a procedural complication. Analyses of biopsy rates employed Poisson regression. Results: Between 1994 and 2002, 3627 patients had 4275 liver biopsies (median 1 per patient; range 1–12). Radiologists performed the majority (90%), particularly during the latter years (1994 vs. 2002: 73 vs. 98%; P<0.0001). The overall annual biopsy rate was 54.8 per 100 000 population with a 41% (95% CI 23–61%) increase between 1994 and 2002. Annual increases were greatest in males and patients 30–59 years. Thirty‐two patients (0.75%) had significant biopsy‐related complications (1994–1997 vs. 1998–2002: 1.28 vs. 0.44%; P=0.003). Pain requiring admission (0.51%) and bleeding (0.35%) were most common. Six patients (0.14%) died; all had malignancies. The median direct cost of a hospitalization for complications was $4579 (range $1164–29 641). Conclusions: Liver biopsy rates are increasing likely owing to the changing epidemiology and management of common liver diseases. The similarity of the complication rate in our population‐based study with estimates from specialized centres supports the safety of this important procedure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Regression Analysis of Count Data
Cameron, A. C., & Trivedi, P. K. (1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511814365 · Cited by 3,147
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Castéra, L., Vergniol, J., Foucher, J., Le Bail, B., Chanteloup, E., Haaser, M., Darriet, M., Couzigou, P., & de Lédinghen, V. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.018 · Cited by 2,487
Bravo, A. A., Sheth, S. G., & Chopra, S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440706 · Cited by 2,041
The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002
Armstrong, G. L., Wasley, A., Simard, E. P., McQuillan, G. M., Kuhnert, W. L., & Alter, M. J. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-10-200605160-00004 · Cited by 1,955
Complications following percutaneous liver biopsy
Piccinino, F., Sagnelli, E., Pasquale, G., Giusti, G., Battocchia, A., Bernardi, M., Bertolazzi, R., Bianchi, F. B., Brunelli, E., Budillon, G., et al. (1986) · Journal of Hepatology · doi:10.1016/s0168-8278(86)80075-7 · Cited by 1,202
The epidemiology of nonalcoholic fatty liver disease in adults.
Clark, J. M. (2006) · PubMed · doi:10.1097/01.mcg.0000168638.84840.ff · Cited by 762
A 21-year experience with major hemorrhage after percutaneous liver biopsy
McGill, D. B., Rakela, J., Zinsmeister, A. R., & Ott, B. J. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91167-5 · Cited by 647
Guidelines on the use of liver biopsy in clinical practice
Grant, A., & Neuberger, J. (1999) · Gut · doi:10.1136/gut.45.2008.iv1 · Cited by 479
Cited by
Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C., & Smith, A. D. (2009) · Hepatology · doi:10.1002/hep.22742 · Cited by 1,997
Seeff, L. B., Everson, G. T., Morgan, T. R., Curto, T. M., Lee, W. M., Ghany, M. G., Shiffman, M. L., Fontana, R. J., Di Bisceglie, A. M., Bonkovsky, H. L., et al. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.03.025 · Cited by 471
Neuberger, J., Patel, J., Caldwell, H., Davies, S., Hebditch, V., Hollywood, C., Hubscher, S., Karkhanis, S., Lester, W., Roslund, N., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-321299 · Cited by 449
Bleeding Complications of Native Kidney Biopsy: A Systematic Review and Meta-analysis
Corapi, K. M., Chen, J. L. T., Balk, E. M., & Gordon, C. E. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.02.330 · Cited by 436
Quality Improvement Guidelines for Percutaneous Needle Biopsy
Gupta, S., Wallace, M. J., Cardella, J. F., Kundu, S., Miller, D. L., & Rose, S. C. (2010) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2010.01.011 · Cited by 345
Metadata
- Authors
- Myers, R. P., Fong, A., & Shaheen, A. A. M.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2008-04-10
- Volume
- 28
- Issue
- 5
- Pages
- 705-712
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2141866917
- Cited by
- 269
- References
- 17
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies. https://app.cochat.ai/papers/10.1111/j.1478-3231.2008.01691.x
- The paper
- Myers, R. P., Fong, A., & Shaheen, A. A. M. (2008). Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsies. Liver International. https://doi.org/10.1111/j.1478-3231.2008.01691.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.